Anthropic 的新戰略：既向生物科技公司出售工具，又自行研發藥物
anthropic 發布了針對科學的 'claude science' 工作台，並宣布計畫自行研發治療被忽視疾病的藥物，這標誌著它從軟體供應商向製藥領域直接參與者的轉型。
anthropic introduced claude science, an integrated workbench for scientists, and declared its intent to develop proprietary drugs, focusing on neglected diseases. while the firm lists major biotech clients, this move pits it against partners like pfizer and merck, creating a complex vendor-customer dynamic. anthropic provided few details on clinical trials or manufacturing, but this escalation mirrors trends by google's isomorphic labs. the strategy proves that frontier labs are moving beyond text generation into high-stakes, real-world biology applications where failures can cost billions.